MYXREDLIN
Google image searchProduct monograph
Active ingredient
insulin (human), 1 UNIT/ML
DIN: 02529602
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: BAXTER CORPORATION
Date: 28-JUL-2023
ATC:
- A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
- A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
- A10AB — Insulins and analogues for injection, fast-acting (ATC, ATC/DDD)
- A10AB01 — INSULIN (HUMAN) (ATC/DDD)
Reference brand drug: Humulin R, Novolin Ge Toronto
Pharmaceutical standard: MFR
